The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19
ACTIV-3/TICO Study Group(National Institute of Allergy and Infectious Diseases), Lavannya M. Pandit(Michael E. DeBakey VA Medical Center), Robin Dewar(Frederick National Laboratory for Cancer Research), Andrew Phillips(Wake Forest University), D. Clark Files(Wake Forest University), Victoria J. Davey(United States Department of Veterans Affairs), Weizhong Chang(Frederick National Laboratory for Cancer Research), M. Tauseef Rehman(Frederick National Laboratory for Cancer Research), Perrine Lallemand(Frederick National Laboratory for Cancer Research), Nila J. Dharan(United States Department of Veterans Affairs), Adit A. Ginde(University of Colorado Anschutz Medical Campus), Kami Kim(University of South Florida), Joseph Lutaakome(UNSW Sydney), Michael A. Matthay(University of California, San Francisco), Virginia L. Kan(University of South Florida), Srikanth Ramachandruni(Frederick National Laboratory for Cancer Research), María L. Padilla(Icahn School of Medicine at Mount Sinai), Brad T. Sherman(Leidos (United States)), Mamta K. Jain(The University of Texas Southwestern Medical Center), Deborah Wentworth(University of Minnesota), Elizabeth S. Higgs(National Institutes of Health), Samuel M. Brown(University of Utah), Ahmad Mourad, Abdel G. Babiker(Frederick National Laboratory for Cancer Research), H Cliff Lane(Rigshospitalet), James D. Neaton(University of Minnesota), Sarah Pett(MRC Clinical Trials Unit at UCL), Ven Natarajan(National Cancer Institute), Helene Highbarger(Frederick National Laboratory for Cancer Research), Jeroen Highbarger(Frederick National Laboratory for Cancer Research), Angela J. Rogers(University of Minnesota), Gail Matthews(UNSW Sydney), Jens D. Lundgren(Rigshospitalet), E B Mylonakis(Brown University), B Thompson(Massachusetts General Hospital), Kathryn Shaw‐Saliba(Harvard University), Norman Gerry(University of Colorado Denver), J.W. Awori Hayanga(Leidos (United States)), Bradley G. Leshnower(Emory University), Roger Paredes(IrsiCaixa), Neil R. Aggarwal(University of Colorado Anschutz Medical Campus)
Cited by 63
Related Papers
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II
|The Lancet|2000|2k
Demographic Differences and Trends of Vitamin D Insufficiency in the US Population, 1988-2004
|Archives of Internal Medicine|2009|1.1k
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
|The Journal of Infectious Diseases|2011|1.1k